WHO ICTRP trial
Effect of two-linked mutations of the FMO3 gene on itopride metabolism
ChiCTR-OCS-14004390 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-OCS-14004390 |
|---|---|
| Public title | Effect of two-linked mutations of the FMO3 gene on itopride metabolism |
| Scientific title | Effect of two-linked mutations of the FMO3 gene on itopride metabolism |
| Primary sponsor | Institute of Clinical Pharmacology |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Healthy volunteers |
| Interventions | 1:itopride |
| Registration date | Feb 23, 2014 |
| Target size | 1:350 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: